Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Cancer Immunol Res. 2019 Jul 23;7(9):1412–1425. doi: 10.1158/2326-6066.CIR-19-0258

Figure 4. ID8VEGF tumors recapitulate immunosuppressive features of the human HGSOC TME.

Figure 4.

A) IHC of ID8VEGF tumors or human metastatic HGSOC tumors for CD68, FoxP3, CD20, PD-L1, CD47, Galectin-9, or Galectin-3. IHC images are representative of 6 mice or 28 human tumor samples. Scale bar = 50 microns.

B) Proportion of samples in which positive staining for each protein was observed.